DSNTV: Chuck Reed, Group VP, Pharmacy Innovation and Solutions, AmerisourceBergen Drug Corp.
Reed told DSN about the work AmerisourceBergen has done to build its Elevate Provider Network into a “smarter” pharmacy services administration organization, enabling its customers to maximize reimbursement opportunities, plug profit leaks, deliver access to patient lives, and perhaps most important, how it is helping its customers to outperform the rest of the pharmacy market in both the EQuIPP Star ratings and prescription growth.
“Seventy percent of our members have a five-star ranking in one or more of the adherence measures in the EQuIPP Star ratings system. Of those, 40% of our stores have one or more scores in the top 20% of all pharmacies,” Reed said. And citing data from IMS for the 12 months ended May 2016, “the market grew at 1.9%,” he told DSN. “Drug chains had only 2.9% growth and independents were flat, yet our independents grew 3.4%.”
DSNTV: Chuck Ball, SVP, Distribution Services, AmerisourceBergen Drug Corp.
Ball talked to DSN about the work the company has done to improve its customer experience, including a massive $1 billion investment in infrastructure that has modernized its supply chain, including several new distribution centers and new technology that is helping to make it easier for its customers to do business with AmerisourceBergen — and helping the company reach new levels of what Ball describes as “operational agility.”
Using the example of a recent major generic drug launch, Ball told DSN about how the investments are allowing AmerisourceBergen to respond faster than ever to customer and manufacturer needs. “Because of FDA requirements, we couldn’t release the orders until 12:01 am that Monday, but the manufacturer wanted distribution to all customers on Monday morning,” he explained, adding that in the past, it would have had to deliver the orders that Tuesday. “I am proud to say we got 99.9% of the product delivered on Monday.”
DSNTV: Peyton Howell, EVP/President, Global Sourcing and Manufacturer Relations, AmerisourceBergen Drug Corp.
Howell, whose team works to connect AmerisourceBergen’s customers with the manufacturer community, discussed the company’s efforts to strengthen its negotiations with vendors and how AmerisourceBergen’s strategic alliance with Walgreens Boots Alliance is allowing it to leverage its massive scale, helping to drive down costs and open up access for independent community pharmacy — a critical focus for her group, she told DSN.
“The No. 1 thing we focus on with manufacturers is patient access,” she said. “That’s important because it’s very easy for a manufacturer to look at a specialty product and limit distribution and access … for community pharmacy. But if the patient is actually presenting in the community pharmacy, you’re really missing the opportunity for that pharmacist to service that patient’s full needs.